Blackstone Inc. INFORMATION TABLE, Q2 FY2022

SEC Filing Summary: Blackstone Inc. (Form 13F)

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted by Blackstone Inc. for the reporting period ending June 30, 2022. The document discloses the equity securities held by the investment manager at the end of the quarter. It does not contain financial statements, revenue data, or management commentary regarding Blackstone's own operational performance.

Key Financial Metrics and Portfolio Composition

The filing lists specific holdings but does not provide aggregate portfolio value, revenue, profit, cash flow, or debt metrics for Blackstone Inc. itself. The table details the following portfolio characteristics:

  • Asset Class: Primarily common stock (COM), limited partnership units (LP), and warrants (W).
  • Valuation: Values are reported in thousands (x$1,000).
  • Voting Authority: Most positions are held with "Other" (OTR) discretion, with specific "Sole" discretion noted for Blackstone Mortgage Trust, Blackstone Secured Lending Fund, and Patria Investments.
  • Top Holdings by Value (Selected):
    • Vivint Smart Home Inc: ~$347.6M (99.9M shares)
    • PaySafe Limited: ~$255.4M (131.0M shares)
    • Oatly Group AB: ~$137.6M (39.8M shares)
    • PG&E Corp: ~$474.8M (47.6M shares)
    • Energy Transfer LP: ~$1.86B aggregate (two positions totaling ~186.7M units)
    • FirstEnergy Corp: ~$1.11B (28.8M shares)
    • Gates Industrial Corp PLC: ~$1.93B aggregate (two positions totaling ~178.6M shares)

Material Changes and Portfolio Strategy

As a quarterly snapshot, this filing does not explicitly state material changes versus the prior period (March 31, 2022) without comparative data. However, the portfolio composition reveals a distinct strategic focus:

  • Energy & Midstream: Significant exposure to energy infrastructure, including Energy Transfer, Enterprise Products Partners, MPLX LP, Kinder Morgan, and Targa Resources.
  • SPACs (Special Purpose Acquisition Companies): A substantial portion of the portfolio consists of SPACs (e.g., Churchill Capital Corp, Gores Technology Partners, various "Acquisition Corp" entities), indicating active participation in the SPAC market during this period.
  • Biotech & Healthcare: Diversified holdings in biotechnology firms such as Talaris Therapeutics, Praxis Precision Medicines, and NGM Biopharmaceuticals.
  • Technology & Consumer: Notable positions in Vivint, Oatly, and ZoomInfo.

Guidance, Risks, and Contingencies

Guidance & Outlook: This filing type does not contain management guidance, earnings outlook, or strategic commentary.

Risks & Contingencies: The filing includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy. The portfolio's heavy weighting in SPACs and volatile sectors (biotech, energy) implies exposure to market volatility and merger execution risks, though these are not explicitly detailed in the text.

Investor Verification Checklist

  • Aggregate AUM: Verify Blackstone's total Assets Under Management (AUM) in their 10-Q or 10-K, as this 13F only covers a subset of equity holdings.
  • SPAC Performance: Assess the current status of the numerous SPAC holdings listed, as many may have completed mergers, liquidated, or expired since June 2022.
  • Energy Sector Exposure: Confirm the current valuation of the significant midstream and energy pipeline positions given commodity price fluctuations.
  • Discretionary Authority: Note the distinction between "Sole" and "Other" voting authority to understand the extent of Blackstone's direct control over specific entities like Blackstone Mortgage Trust.
  • Warrant Expirations: Review the expiration dates listed for warrant positions (e.g., Hudson Executive Invs, Infinite Acquisition) to determine if they are still exercisable.